Get started
Author

Oyewale O. Abidoye

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
2016 · Jonathan E Rosenberg, Jean Hoffman-Censits, et al. · The Lancet · 3,645
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
2016 · Arjun V Balar, Matthew D Galsky, et al. · The Lancet · 2,189
Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Metastatic Urothelial Carcinoma
2016 · M Stroh, H Winter, et al. · Clinical Pharmacology & Therapeutics · 159
MET as a target for treatment of chest tumors
2008 · Nicole A. Cipriani, Oyewale O. Abidoye, et al. · Lung Cancer · 120
IMvigor 210, a phase II trial of atezolizumab (MPDL3280A) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC).
2016 · Jean H. Hoffman-Censits, Petros Grivas, et al. · Journal of Clinical Oncology · 83
A phase II study of lapatinib (GW572016) in recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN)
2006 · O. O. Abidoye, E. E. Cohen, et al. · Journal of Clinical Oncology · 79
A phase Ia study of MPDL3280A (anti-PDL1): Updated response and survival data in urothelial bladder cancer (UBC).
2015 · Daniel Peter Petrylak, Thomas Powles, et al. · Journal of Clinical Oncology · 63
Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer
2013 · Hope S. Rugo, Adam M. Brufsky, et al. · Breast Cancer Research and Treatment · 52
PDF
Clinical Impact of Chemotherapy-Related Adverse Events in Patients with Metastatic Breast Cancer in an Integrated Health Care System
2015 · Nazia Rashid, Han A. Koh, et al. · Journal of Managed Care & Specialty Pharmacy · 51
PDF
Lung carcinoma in African Americans
2007 · Oyewale Abidoye, Mark K Ferguson, et al. · Nature Clinical Practice Oncology · 45
Atezolizumab (atezo) as first-line (1L) therapy in cisplatin-ineligible locally advanced/metastatic urothelial carcinoma (mUC): Primary analysis of IMvigor210 cohort 1.
2016 · Arjun Vasant Balar, Matt D. Galsky, et al. · Journal of Clinical Oncology · 31
Review of Clinic Trials: Agents Targeting c-Met
2007 · Oyewale Abidoye, Nadh Murukurthy, et al. · Reviews on Recent Clinical Trials · 31
Atezolizumab (atezo) in platinum (plat)-treated locally advanced/metastatic urothelial carcinoma (mUC): Updated OS, safety and biomarkers from the Ph II IMvigor210 study
2016 · Y. Loriot, J.E. Rosenberg, et al. · Annals of Oncology · 24
EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC
2008 · Martin Sattler, Oyewale Abidoye, et al. · The Scientific World JOURNAL · 22
PDF
Neo‐adjuvant Capecitabine Chemotherapy in Women with Newly Diagnosed Locally Advanced Breast Cancer in a Resource‐poor Setting (Nigeria): Efficacy and Safety in a Phase II Feasibility Study
2013 · Olukayode A. Arowolo, Uchenna O. Njiaju, et al. · The Breast Journal · 19
PDF
Updated efficacy and > 1-y follow up from IMvigor210: Atezolizumab (atezo) in platinum (plat) treated locally advanced/metastatic urothelial carcinoma (mUC).
2016 · Robert Dreicer, Jean H. Hoffman-Censits, et al. · Journal of Clinical Oncology · 15
21LBA Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210)
2015 · J. Rosenberg, D. Petrylak, et al. · European Journal of Cancer · 14
Early treatment discontinuation and switching in first-line metastatic breast cancer: the role of patient-reported symptom burden
2014 · Mark S. Walker, Anthony S. Masaquel, et al. · Breast Cancer Research and Treatment · 10
Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Outcomes by prior therapy.
2017 · Jose Luis Perez-Gracia, Yohann Loriot, et al. · Journal of Clinical Oncology · 7
Atezolizumab (atezo) as first-line (1L) therapy in cisplatin-ineligible locally advanced/metastatic urothelial carcinoma (mUC): Primary analysis of IMvigor210 cohort 1.
2016 · Arjun Vasant Balar, Matt D. Galsky, et al. · Journal of Clinical Oncology · 7
The Impact Of Non-Muscle Invasive Bladder Cancer: Qualitative Research With Patients
2015 · M Clark, NI Harris, et al. · Value in Health · 3
Impacts of toxicity on patient treatment choices for metastatic breast cancer.
2012 · Carol B. White, Mary Lou Smith, et al. · Journal of Clinical Oncology · 3
Trastuzumab emtansine (T-DM1) in previously treated HER2-positive metastatic breast cancer (MBC): Results from an expanded access study.
2013 · Denise Aysel Yardley, Ian E. Krop, et al. · Journal of Clinical Oncology · 1
Real-world symptom burden and early treatment discontinuation in first-line metastatic breast cancer (MBC).
2013 · Mark S. Walker, Anthony Masaquel, et al. · Journal of Clinical Oncology · 1
Abstract P6-09-11: Examining patient treatment choices involving efficacy, toxicity, and cost tradeoffs in the metastatic breast cancer setting
2012 · CB White, ML Smith, et al. · Cancer Research · 1
Works count: 35
Citation count: 6,676
H-index: 15
I10-index: 18
Year
Topic
Type